Research progress on the molecular mechanisms of Saikosaponin D in various diseases (Review)
- Authors:
- Simin Gu
- Yiyuan Zheng
- Chong Chen
- Jing Liu
- Yanping Wang
- Junmin Wang
- Yong Li
-
Affiliations: Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China - Published online on: December 24, 2024 https://doi.org/10.3892/ijmm.2024.5478
- Article Number: 37
-
Copyright: © Gu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Zulkifli MH, Abdullah ZL, Mohamed Yusof NIS and Mohd Fauzi F: In silico toxicity studies of traditional Chinese herbal medicine: A mini review. Curr Opin Struct Biol. 80:1025882023. View Article : Google Scholar : PubMed/NCBI | |
|
Qian Z, Wang GY, Henning M and Chen Y: Understanding health literacy from a traditional Chinese medicine perspective. J Integr Med. 21:215–220. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Ai C, Zou Y, Liu H, Yang Z and Xi J: Traditional Chinese herbal medicine for allergic diseases: A review. Am J Chin Med. 51:779–806. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Y, Shao M, Xiang H, Wang J, Ji G and Wu T: Qinggan huoxue recipe alleviates alcoholic liver injury by suppressing endoplasmic reticulum stress through LXR-LPCAT3. Front Pharmacol. 13:8241852022. View Article : Google Scholar : PubMed/NCBI | |
|
Sun L, Yang Z, Zhao W, Chen Q, Bai H, Wang S, Yang L, Bi C, Shi Y and Liu Y: Integrated lipidomics, transcriptomics and network pharmacology analysis to reveal the mechanisms of Danggui Buxue Decoction in the treatment of diabetic nephropathy in type 2 diabetes mellitus. J Ethnopharmacol. 283:1146992022. View Article : Google Scholar | |
|
Xiang H, Shao M, Lu Y, Wang J, Wu T and Ji G: Kaempferol alleviates steatosis and inf lammation during early Non-Alcoholic steatohepatitis associated with liver X Receptor α-Lysophosphatidylcholine acyltransferase 3 signaling pathway. Front Pharmacol. 12:6907362021. View Article : Google Scholar | |
|
Paik S, Song GY and Jo EK: Ginsenosides for therapeutically targeting inflammation through modulation of oxidative stress. Int Immunopharmacol. 121:1104612023. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Li F and Jin D: Ginsenosides are promising medicine for tumor and inflammation: A review. Am J Chin Med. 51:883–908. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Zarneshan SN, Fakhri S and Khan H: Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach. Pharmacol Res. 177:1060992022. View Article : Google Scholar : PubMed/NCBI | |
|
Teng L, Guo X, Ma Y, Xu L, Wei J and Xiao P: A comprehensive review on traditional and modern research of the genus Bupleurum (Bupleurum L., Apiaceae) in recent 10 years. J Ethnopharmacol. 306:1161292023. View Article : Google Scholar : PubMed/NCBI | |
|
Sui C, Han WJ, Zhu CR and Wei JH: Recent progress in saikosaponin biosynthesis in bupleurum. Curr Pharm Biotechnol. 22:329–340. 2021. View Article : Google Scholar | |
|
Shao S, Jia R, Zhao L, Zhang Y, Guan Y, Wen H, Liu J, Zhao Y, Feng Y, Zhang Z, et al: Xiao-Chai-Hu-Tang ameliorates tumor growth in cancer comorbid depressive symptoms via modulating gut microbiota-mediated TLR4/MyD88/NF-κB signaling pathway. Phytomedicine. 88:1536062021. View Article : Google Scholar | |
|
Fan Q, Liu Y, Sheng L, Lv S, Yang L, Zhang Z, Guo J, Fan Y and Hu D: Chaihu-Shugan-San inhibits neuroinflammation in the treatment of post-stroke depression through the JAK/STAT3-GSK3β/PTEN/Akt pathway. Biomed Pharmacother. 160:1143852023. View Article : Google Scholar | |
|
Jiao H, Fan Y, Gong A, Li T, Fu X and Yan Z: Xiaoyaosan ameliorates CUMS-induced depressive-like and anorexia behaviors in mice via necroptosis related cellular senescence in hypothalamus. J Ethnopharmacol. 318:1169382024. View Article : Google Scholar | |
|
Luo K, Dai RJ, Zeng YB, Chang WJ, Deng YL and Lv F: Triterpenoid saponins from Bupleurum marginatum and their anti-liver fibrotic activities. J Asian Nat Prod Res. 26:858–864. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Kang Y, Gao Y, Li X, Guo X, Liu Z, Li W, Wei J and Qi Y: Bupleurum chinense exerts a mild antipyretic effect on LPS-induced pyrexia rats involving inhibition of peripheral TNF-α production. J Ethnopharmacol. 310:1163752023. View Article : Google Scholar | |
|
Zhou J, He X, Sun R, Yu Z, Wang C, Deng S, Zhang B, Huang S, Han C and Li D: Lignans from Bupleurum marginatum and their antioxidant activity. Nat Prod Res. 36:5016–5021. 2022. View Article : Google Scholar | |
|
Sun P, Li Y, Wei S, Zhao T, Wang Y, Song C, Xue L, Wang F, Xiao L, Wu J and Qiao M: Pharmacological effects and chemical constituents of bupleurum. Mini Rev Med Chem. 19:34–55. 2019. View Article : Google Scholar | |
|
Li XQ, Song YN, Wang SJ, Rahman K, Zhu JY and Zhang H: Saikosaponins: A review of pharmacological effects. J Asian Nat Prod Res. 20:399–411. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang YJ, Wu SS, Chen XM, Pi JK, Cheng YF, Zhang Y, Wang XJ, Luo D, Zhou JH, Xu JY, et al: Saikosaponin D Alleviates DOX-induced cardiac injury in vivo and in vitro. J Cardiovasc Pharmacol. 79:558–567. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang HW, Liu M, Zhong TD and Fang XM: Saikosaponin-d attenuates ventilator-induced lung injury in rats. Int J Clin Exp Med. 8:15137–15145. 2015.PubMed/NCBI | |
|
Li X, Ge J, Li Y, Cai Y, Zheng Q, Huang N, Gu Y, Han Q, Li Y, Sun R, et al: Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease. Acta Pharm Sin B. 11:3527–3541. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Fan J, Li X, Li P, Li N, Wang T, Shen H, Siow Y, Choy P and Gong Y: Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury. Biochem Cell Biol. 85:189–195. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Yao T, Zhang L, Fu Y, Yao L, Zhou C and Chen G: Saikosaponin-d alleviates renal inflammation and cell apoptosis in a mouse model of sepsis via TCF7/FOSL1/matrix metalloproteinase 9 inhibition. Mol Cell Biol. 41:e00332212021. View Article : Google Scholar : PubMed/NCBI | |
|
Xiang Q, Liu Y and Chen L: Saikosaponin d (SSD) alleviates diabetic peripheral neuropathy by regulating the AQP1/RhoA/ROCK signaling in streptozotocin-induced diabetic rats. Acta Diabetol. 60:805–815. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Gao T, Wang T, Wu L, Tong Y, Tian J, Zhao K and Wang H: Saikosaponin-d alleviates depression by promoting NLRP3 ubiquitination and inhibiting inflammasome activation. Int Immunopharmacol. 127:1113242024. View Article : Google Scholar | |
|
Lixing X, Zhouye J, Liting G, Ruyi Z, Rong Q and Shiping M: Saikosaponin-d-mediated downregulation of neurogenesis results in cognitive dysfunction by inhibiting Akt/Foxg-1 pathway in mice. Toxicol Lett. 284:79–85. 2018. View Article : Google Scholar | |
|
Hu J, Li P, Shi B and Tie J: Effects and mechanisms of saikosaponin D improving the sensitivity of human gastric cancer cells to cisplatin. ACS Omega. 6:18745–18755. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen LL, Xia LY, Zhang JP, Wang Y, Chen JY, Guo C and Xu WH: Saikosaponin D alleviates cancer cachexia by directly inhibiting STAT3. Phytother Res. 37:809–819. 2023. View Article : Google Scholar | |
|
Wang P, Ren J, Tang J, Zhang D, Li B and Li Y: Estrogen-like activities of saikosaponin-d in vitro: A pilot study. Eur J Pharmacol. 626:159–165. 2010. View Article : Google Scholar | |
|
Que R, Shen Y, Ren J, Tao Z, Zhu X and Li Y: Estrogen receptor-β-dependent effects of saikosaponin-d on the suppression of oxidative stress-induced rat hepatic stellate cell activation. Int J Mol Med. 41:1357–1364. 2018. | |
|
Lin L, Zhou M, Que R, Chen Y, Liu X, Zhang K, Shi Z and Li Y: Saikosaponin-d protects against liver fibrosis by regulating the estrogen receptor-β/NLRP3 inflammasome pathway. Biochem Cell Biol. 99:666–674. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang K, Lin L, Zhu Y, Zhang N, Zhou M and Li Y: Saikosaponin d alleviates liver fibrosis by negatively regulating the ROS/NLRP3 inflammasome through activating the ERβ pathway. Front Pharmacol. 13:8949812022. View Article : Google Scholar | |
|
Kumazawa Y, Takimoto H, Nishimura C, Kawakita T and Nomoto K: Activation of murine peritoneal macrophages by saikosaponin a, saikosaponin d and saikogenin d. Int J Immunopharmacol. 11:21–28. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Luo SQ, Lin LZ and Cordell GA: Saikosaponin derivatives from Bupleurum wenchuanense. Phytochemistry. 33:1197–1205. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Lu CN, Yuan ZG, Zhang XL, Yan R, Zhao YQ, Liao M and Chen JX: Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-κB signaling pathway. Int Immunopharmacol. 14:121–126. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Li C, Cui L, Zhang L, Yang L, Zhuo Y, Cui J, Cui N and Zhang S: Saikosaponin D attenuates pancreatic injury through suppressing the apoptosis of acinar cell via modulation of the MAPK signaling pathway. Front Pharmacol. 12:7350792021. View Article : Google Scholar : PubMed/NCBI | |
|
Kassis S, Grondin M and Averill-Bates DA: Heat shock increases levels of reactive oxygen species, autophagy and apoptosis. Biochim Biophys Acta Mol Cell Res. 1868:1189242021. View Article : Google Scholar | |
|
Zhang BZ, Guo XT, Chen JW, Zhao Y, Cong X, Jiang ZL, Cao RF, Cui K, Gao SS and Tian WR: Saikosaponin-D attenuates heat stress-induced oxidative damage in LLC-PK1 cells by increasing the expression of anti-oxidant enzymes and HSP72. Am J Chin Med. 42:1261–1277. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lin X, Wu S, Wang Q, Shi Y, Liu G, Zhi J and Wang F: Saikosaponin-D reduces H2O2-induced PC12 cell apoptosis by removing ROS and blocking MAPK-dependent oxidative damage. Cell Mol Neurobiol. 36:1365–1375. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Huang M, Yan Y, Deng Z, Zhou L, She M, Yang Y, Zhang M and Wang D: Saikosaponin A and D attenuate skeletal muscle atrophy in chronic kidney disease by reducing oxidative stress through activation of PI3K/AKT/Nrf2 pathway. Phytomedicine. 114:1547662023. View Article : Google Scholar : PubMed/NCBI | |
|
Su W, Huang S, Zhu H, Zhang B and Wu X: Interaction between PHB2 and Enterovirus A71 VP1 Induces Autophagy and Affects EV-A71 Infection. Viruses. 12:4142020. View Article : Google Scholar : PubMed/NCBI | |
|
Li C, Huang L, Sun W, Chen Y, He ML, Yue J and Ballard H: Saikosaponin D suppresses enterovirus A71 infection by inhibiting autophagy. Signal Transduct Target Ther. 4:42019. View Article : Google Scholar : PubMed/NCBI | |
|
Sun J, Zheng J, Shi X, Qian H, Jin C and Xu L: Saikosaponin D inhibits proliferation and collagen production of human embryonic lung fibroblasts by regulating TGF-β1/Smads signaling pathway. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 35:256–261. 2019.In Chinese. PubMed/NCBI | |
|
Du P, Xu J, Jiang Y, Zhao J, Gao C, Fang Y, Yang X, Yang YP and Zhang JA: Saikosaponin-d attenuates hashimoto's thyroiditis by regulating macrophage polarization. J Immunol Res. 2022:74554942022. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Liu C, Zhao R, Zhao P, Wu J, Zhou N and Ying M: Synergetic and antagonistic molecular effects mediated by the feedback loop of p53 and JNK between Saikosaponin D and SP600125 on lung cancer A549 cells. Mol Pharm. 15:4974–4984. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lai M, Ge Y, Chen M, Sun S, Chen J and Cheng R: Saikosaponin D inhibits proliferation and promotes apoptosis through activation of MKK4-JNK signaling pathway in pancreatic cancer cells. Onco Targets Ther. 13:9465–9479. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wu S, Chen W, Liu K, Ren F, Zheng D, Xu F and Wu H: Saikosaponin D inhibits proliferation and induces apoptosis of non-small cell lung cancer cells by inhibiting the STAT3 pathway. J Int Med Res. 48:3000605209371632020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Qi H, Zhang X, Si W, Xu F, Hou T, Zhou H, Wang A, Li G, Liu Y, et al: Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling. Biomed Pharmacother. 108:724–733. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen M, Hu C, Yang L, Guo Q, Liang Y and Wang W: Saikosaponin-D induces the pyroptosis of lung cancer by increasing ROS and activating the NF-κB/NLRP3/caspase-1/GSDMD pathway. J Biochem Mol Toxicol. 37:e234442023. View Article : Google Scholar | |
|
Li P, Gong Y, Zu N, Li Y, Wang B and Shimizu F: Therapeutic mechanism of Saikosaponin-d in anti-Thy1 mAb 1-22-3-induced rat model of glomerulonephritis. Nephron Exp Nephrol. 101:e111–118. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Hsu YL, Kuo PL and Lin CC: The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells. Life Sci. 75:1231–1242. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Wong VK, Zhang MM, Zhou H, Lam KY, Chan PL, Law CK, Yue PY and Liu L: Saikosaponin-d enhances the anticancer potency of TNF-α via overcoming its undesirable response of activating NF-Kappa B signalling in cancer cells. Evid Based Complement Alternat Med. 2013:7452952013. View Article : Google Scholar | |
|
Rawat PS, Jaiswal A, Khurana A, Bhatti JS and Navik U: Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed Pharmacother. 139:1117082021. View Article : Google Scholar : PubMed/NCBI | |
|
Song L, Lu G and Tao Y: Saikosaponin D attenuates inflammatory response and cell apoptosis of lipopolysaccharide-induced lung epithelial cells. Clin Respir J. 17:1017–1024. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Moss BJ, Ryter SW and Rosas IO: Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annu Rev Pathol. 17:515–546. 2022. View Article : Google Scholar | |
|
Wu Y, Zhang J, Wang X, Xu Y and Zheng J: Saikosaponin-d regulates angiogenesis in idiopathic pulmonary fibrosis through angiopoietin/Tie-2 pathway. Acta Histochem. 125:1521002023. View Article : Google Scholar : PubMed/NCBI | |
|
Jaeschke H, Akakpo JY, Umbaugh DS and Ramachandran A: Novel therapeutic approaches against acetaminophen-induced liver injury and acute liver failure. Toxicol Sci. 174:159–167. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu A, Tanaka N, Sun L, Guo B, Kim JH, Krausz KW, Fang Z, Jiang C, Yang J and Gonzalez FJ: Saikosaponin d protects against acetaminophen-induced hepatotoxicity by inhibiting NF-κB and STAT3 signaling. Chem Biol Interact. 223:80–86. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lin L, Que R, Shen Y, Chen Y, Yan N and Li Y: Saikosaponin-d alleviates carbon-tetrachloride induced acute hepatocellular injury by inhibiting oxidative stress and NLRP3 inflammasome activation in the HL-7702 cell line. Mol Med Rep. 17:7939–7946. 2018.PubMed/NCBI | |
|
Chen Y, Que R, Lin L, Shen Y, Liu J and Li Y: Inhibition of oxidative stress and NLRP3 inflammasome by Saikosaponin-d alleviates acute liver injury in carbon tetrachloride-induced hepatitis in mice. Int J Immunopathol Pharmacol. 34:20587384209505932020. View Article : Google Scholar : PubMed/NCBI | |
|
Singal AK, Bataller R, Ahn J, Kamath PS and Shah VH: ACG Clinical Guideline: Alcoholic liver disease. Am J Gastroenterol. 113:175–194. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tsuchida T and Friedman SL: Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 14:397–411. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang H, Liu J, Zhang K and Zeng Q: Saikosaponin D inhibits the proliferation and promotes the apoptosis of rat hepatic stellate cells by inducing autophagosome formation. Evid Based Complement Alternat Med. 2021:54517582021. View Article : Google Scholar : PubMed/NCBI | |
|
Yu X, Pan J, Shen N, Zhang H, Zou L, Miao H and Xing L: Development of Saikosaponin D liposome nanocarrier with increased hepatoprotective effect against alcoholic hepatitis mice. J Biomed Nanotechnol. 17:627–639. 2021. View Article : Google Scholar | |
|
Byrne CD and Targher G: NAFLD: A multisystem disease. J Hepatol. 62(1 Suppl): S47–S64. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lim SH, Lee HS, Han HK and Choi CI: Saikosaponin A and D inhibit adipogenesis via the AMPK and MAPK signaling pathways in 3T3-L1 adipocytes. Int J Mol Sci. 22:114092021. View Article : Google Scholar : PubMed/NCBI | |
|
Gu Y, Duan S, Ding M, Zheng Q, Fan G, Li X, Li Y, Liu C, Sun R and Liu R: Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway. Phytomedicine. 103:1542192022. View Article : Google Scholar | |
|
Abe H, Sakaguchi M, Odashima S and Arichi S: Protective effect of saikosaponin-d isolated from Bupleurum falcatum L. on CCl4-induced liver injury in the rat. Naunyn Schmiedebergs Arch Pharmacol. 320:266–271. 1982. View Article : Google Scholar : PubMed/NCBI | |
|
Dang SS, Wang BF, Cheng YA, Song P, Liu ZG and Li ZF: Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats. World J Gastroenterol. 13:557–563. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Chen MF, Huang CC, Liu PS, Chen CH and Shiu LY: Saikosaponin a and saikosaponin d inhibit proliferation and migratory activity of rat HSC-T6 cells. J Med Food. 16:793–800. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen MF, Huang SJ, Huang CC, Liu PS, Lin KI, Liu CW, Hsieh WC, Shiu LY and Chen CH: Saikosaponin d induces cell death through caspase-3-dependent, caspase-3-independent and mitochondrial pathways in mammalian hepatic stellate cells. BMC Cancer. 16:5322016. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Que R, Zhang N, Lin L, Zhou M and Li Y: Saikosaponin-d alleviates hepatic fibrosis through regulating GPER1/autophagy signaling. Mol Biol Rep. 48:7853–7863. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng Y, Zhou L, Wan Y, Fu T, Xu P, Zhang H and Guan Y: Effects of Saikosaponin D on apoptosis, autophagy, and morphological structure of intestinal cells of cajal with functional dyspepsia. Comb Chem High Throughput Screen. 27:1513–1522. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Li P, Wu M, Xiong W, Li J, An Y, Ren J, Xie Y, Xue H, Yan D, Li M, et al: Saikosaponin-d ameliorates dextran sulfate sodium-induced colitis by suppressing NF-κB activation and modulating the gut microbiota in mice. Int Immunopharmacol. 81:1062882020. View Article : Google Scholar | |
|
Habtezion A: Inflammation in acute and chronic pancreatitis. Curr Opin Gastroenterol. 31:395–399. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Cui LH, Li CX, Zhuo YZ, Yang L, Cui NQ and Zhang SK: Saikosaponin d ameliorates pancreatic fibrosis by inhibiting autophagy of pancreatic stellate cells via PI3K/Akt/mTOR pathway. Chem Biol Interact. 300:18–26. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Abe H, Orita M, Konishi H, Arichi S and Odashima S: Effects of saikosaponin-d on aminonucleoside nephrosis in rats. Eur J Pharmacol. 120:171–178. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao L, Zhang H, Bao J, Liu J and Ji Z: Saikosaponin-d protects renal tubular epithelial cell against high glucose induced injury through modulation of SIRT3. Int J Clin Exp Med. 8:6472–6481. 2015.PubMed/NCBI | |
|
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105(Suppl): S117–S314. 2024. View Article : Google Scholar | |
|
Loren P, Lugones Y, Saavedra N, Saavedra K, Páez I, Rodriguez N, Moriel P and Salazar LA: MicroRNAs involved in intrinsic apoptotic pathway during Cisplatin-induced nephrotoxicity: Potential use of natural products against DDP-induced apoptosis. Biomolecules. 12:12062022. View Article : Google Scholar : PubMed/NCBI | |
|
Ma X, Dang C, Kang H, Dai Z, Lin S, Guan H, Liu X, Wang X and Hui W: Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways. Int Immunopharmacol. 28:399–408. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tomino Y: Mechanisms and interventions in peritoneal fibrosis. Clin Exp Nephrol. 16:109–114. 2012. View Article : Google Scholar | |
|
Ruiqi L, Ming P, Qihang S, Yangyang L, Junli C, Wei L, Chao G, Xinyue L, Kang Y and Hongtao Y: Saikosaponin D inhibits peritoneal fibrosis in rats with renal failure by regulation of TGFβ1/BMP7/Gremlin1/Smad pathway. Front Pharmacol. 12:6286712021. View Article : Google Scholar | |
|
Sun Y, Zhang H, Zhang X, Wang W, Chen Y, Cai Z, Wang Q, Wang J and Shi Y: Promotion of astrocyte-neuron glutamate-glutamine shuttle by SCFA contributes to the alleviation of Alzheimer's disease. Redox Biol. 62:1026902023. View Article : Google Scholar : PubMed/NCBI | |
|
Bai R, Guo J, Ye XY, Xie Y and Xie T: Oxidative stress: The core pathogenesis and mechanism of Alzheimer's disease. Ageing Res Rev. 77:1016192022. View Article : Google Scholar : PubMed/NCBI | |
|
Du J, Song D, Li Y, Liu J, Huang X, Li B and Li L: Saikosaponin-D mitigates oxidation in SH-SY5Y cells stimulated by glutamate through activation of Nrf2 pathway: Involvement of PI3K. Neurotox Res. 40:230–240. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Qin T, Yuan Z, Yu J, Fu X, Deng X, Fu Q, Ma Z and Ma S: Saikosaponin-d impedes hippocampal neurogenesis and causes cognitive deficits by inhibiting the survival of neural stem/progenitor cells via neurotrophin receptor signaling in mice. Clin Transl Med. 10:e2432020. View Article : Google Scholar : PubMed/NCBI | |
|
Smith K: Mental health: A world of depression. Nature. 515:1812014. View Article : Google Scholar : PubMed/NCBI | |
|
Li HY, Zhao YH, Zeng MJ, Fang F, Li M, Qin TT, Ye LY, Li HW, Qu R and Ma SP: Saikosaponin D relieves unpredictable chronic mild stress induced depressive-like behavior in rats: Involvement of HPA axis and hippocampal neurogenesis. Psychopharmacology (Berl). 234:3385–3394. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chao B, Huang S, Pan J, Zhang Y and Wang Y: Saikosaponin d downregulates microRNA-155 and upregulates FGF2 to improve depression-like behaviors in rats induced by unpredictable chronic mild stress by negatively regulating NF-κB. Brain Res Bull. 157:69–76. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu CY, Chen JB, Liu YY, Zhou XM, Zhang M, Jiang YM, Ma QY, Xue Z, Zhao ZY, Li XJ, et al: Saikosaponin D exerts antidepressant effect by regulating Homer1-mGluR5 and mTOR signaling in a rat model of chronic unpredictable mild stress. Chin Med. 17:602022. View Article : Google Scholar : PubMed/NCBI | |
|
Su J, Pan YW, Wang SQ, Li XZ, Huang F and Ma SP: Saikosaponin-d attenuated lipopolysaccharide-induced depressive-like behaviors via inhibiting microglia activation and neuroinflammation. Int Immunopharmacol. 80:1061812020. View Article : Google Scholar : PubMed/NCBI | |
|
Papatheodorou K, Banach M, Bekiari E, Rizzo M and Edmonds M: Complications of Diabetes 2017. J Diabetes Res. 2018:30861672018. View Article : Google Scholar : PubMed/NCBI | |
|
Ralli M, Angeletti D, Fiore M, D'Aguanno V, Lambiase A, Artico M, de Vincentiis M and Greco A: Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 19:1026492020. View Article : Google Scholar : PubMed/NCBI | |
|
Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, Goldring MB, Goldring SR, Jones G, Teichtahl AJ and Pelletier JP: Osteoarthritis. Nat Rev Dis Primers. 2:160722016. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang J, Meng Y, Hu S, Botchway BOA, Zhang Y and Liu X: Saikosaponin D: A potential therapeutic drug for osteoarthritis. J Tissue Eng Regen Med. 14:1175–1184. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wu X, Zhao K, Fang X, Lu F, Cheng P, Song X, Zhang W, Yao C, Zhu J and Chen H: Saikosaponin D inhibited IL-1β induced ATDC 5 chondrocytes apoptosis in vitro and delayed articular cartilage degeneration in OA model mice in vivo. Front Pharmacol. 13:8459592022. View Article : Google Scholar | |
|
Yan M, Zhang D and Yang M: Saikosaponin D alleviates inflammatory response of osteoarthritis and mediates autophagy via elevating microRNA-199-3p to target transcription Factor-4. J Orthop Surg Res. 19:1512024. View Article : Google Scholar : PubMed/NCBI | |
|
Liu RY and Li JP: Saikosaponin-d inhibits proliferation of human undifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest. Eur Rev Med Pharmacol Sci. 18:2435–2443. 2014.PubMed/NCBI | |
|
Passaro A, Jänne PA, Mok T and Peters S: Overcoming therapy resistance in EGFR-mutant lung cancer. Nat Cancer. 2:377–391. 2021. View Article : Google Scholar | |
|
Tang JC, Long F, Zhao J, Hang J, Ren YG, Chen JY and Mu B: The Effects and mechanisms by which Saikosaponin-D enhances the sensitivity of human non-small cell lung cancer cells to gefitinib. J Cancer. 10:6666–6672. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Dong J, Yuan L, Hu C, Cheng X and Qin JJ: Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review. Pharmacol Ther. 249:1084882023. View Article : Google Scholar : PubMed/NCBI | |
|
Li C, Guan X, Xue H, Wang P, Wang M and Gai X: Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Pathol Res Pract. 213:848–853. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li C, Xue HG, Feng LJ, Wang ML, Wang P and Gai XD: The effect of saikosaponin D on doxorubicin pharmacokinetics and its MDR reversal in MCF-7/adr cell xenografts. Eur Rev Med Pharmacol Sci. 21:4437–4445. 2017.PubMed/NCBI | |
|
Fu R, Zhang L, Li Y, Li B, Ming Y, Li Z, Xing H and Chen J: Saikosaponin D inhibits autophagosome-lysosome fusion and induces autophagy-independent apoptosis in MDA-MB-231 breast cancer cells. Mol Med Rep. 22:1026–1034. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang T, Li X, Wang X, Meng X, Zhang Z, Zhao M and Su R: Combination of histological and metabolomic assessments to evaluate the potential pharmacological efficacy of saikosaponin D. J Pharm Biomed Anal. 242:1160012024. View Article : Google Scholar : PubMed/NCBI | |
|
Wen N, Cai Y, Li F, Ye H, Tang W, Song P and Cheng N: The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update. Biosci Trends. 16:20–30. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Jia X, Dang S, Cheng Y, Zhang X, Li M, Li Y and Li S: Effects of saikosaponin-d on syndecan-2, matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in rats with hepatocellular carcinoma. J Tradit Chin Med. 32:415–422. 2012. View Article : Google Scholar | |
|
Chen Y, Chen HN, Wang K, Zhang L, Huang Z, Liu J, Zhang Z, Luo M, Lei Y, Peng Y, et al: Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. J Hepatol. 70:66–77. 2019. View Article : Google Scholar | |
|
Pang C, Miao H, Zuo Y, Guo N, Sun D and Li B: C/EBPβ enhances efficacy of sorafenib in hepatoblastoma. Cell Biol Int. 45:1897–1905. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
He SX, Luo JY, Zhao G, Xu JL, Wang YL, Fu H and Dong L: Effect of saikosaponins-d on cyclooxygenase-2 expression of human hepatocellular carcinoma cell line SMMC-7721. Zhonghua Gan Zang Bing Za Zhi. 14:712–714. 2006.In Chinese. PubMed/NCBI | |
|
Lu XL, He SX, Ren MD, Wang YL, Zhang YX and Liu EQ: Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: Involvement of CCAAT/enhancer binding protein β and cyclooxygenase-2. Mol Med Rep. 5:637–644. 2012. | |
|
He S, Lu G, Hou H, Zhao Z, Zhu Z, Lu X, Chen J and Wang Z: Saikosaponin-d suppresses the expression of cyclooxygenase-2 through the phospho-signal transducer and activator of transcription 3/hypoxia-inducible factor-1α pathway in hepatocellular carcinoma cells. Mol Med Rep. 10:2556–2562. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ren M, McGowan E, Li Y, Zhu X, Lu X, Zhu Z, Lin Y and He S: Saikosaponin-d Suppresses COX2 Through p-STAT3/C/EBPβ signaling pathway in liver cancer: A novel mechanism of action. Front Pharmacol. 10:6232019. View Article : Google Scholar | |
|
Wang BF, Dai ZJ, Wang XJ, Bai MH, Lin S, Ma HB, Wang YL, Song LQ, Ma XL, Zan Y, et al: Saikosaponin-d increases the radiosensitivity of smmc-7721 hepatocellular carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the cell cycle. BMC Complement Altern Med. 13:2632013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang BF, Wang XJ, Kang HF, Bai MH, Guan HT, Wang ZW, Zan Y, Song LQ, Min WL, Lin S, et al: Saikosaponin-D enhances radiosensitivity of hepatoma cells under hypoxic conditions by inhibiting hypoxia-inducible factor-1α. Cell Physiol Biochem. 33:37–51. 2014. View Article : Google Scholar | |
|
Ciepla P, Konitsiotis AD, Serwa RA, Masumoto N, Leong WP, Dallman MJ, Magee AI and Tate EW: New chemical probes targeting cholesterylation of Sonic Hedgehog in human cells and zebrafish. Chem Sci. 5:4249–4259. 2014. View Article : Google Scholar | |
|
Zhang Z, Zhan X, Kim B and Wu J: A proteomic approach identifies SAFB-like transcription modulator (SLTM) as a bidirectional regulator of GLI family zinc finger transcription factors. J Biol Chem. 294:5549–5561. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hendriks IA and Vertegaal AC: A comprehensive compilation of SUMO proteomics. Nat Rev Mol Cell Biol. 17:581–595. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang CY, Jiang ZM, Ma XF, Li Y, Liu XZ, Li LL, Wu WH and Wang T: Saikosaponin-d Inhibits the hepatoma cells and enhances chemosensitivity through SENP5-dependent inhibition of Gli1 SUMOylation under hypoxia. Front Pharmacol. 10:10392019. View Article : Google Scholar : PubMed/NCBI | |
|
Tian YD, Lin S, Yang PT, Bai MH, Jin YY, Min WL, Ma HB and Wang BF: Saikosaponin-d increases the radiosensitivity of hepatoma cells by adjusting cell autophagy. J Cancer. 10:4947–4953. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang B, Min W, Lin S, Song L, Yang P, Ma Q and Guo J: Saikosaponin-d increases radiation-induced apoptosis of hepatoma cells by promoting autophagy via inhibiting mTOR phosphorylation. Int J Med Sci. 18:1465–1473. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Lv Y, Hou X, Zhang Q, Li R, Xu L, Chen Y, Tian Y, Sun R, Zhang Z and Xu F: Untargeted metabolomics study of the in vitro anti-hepatoma effect of saikosaponin d in combination with NRP-1 knockdown. Molecules. 24:14232019. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Tang Y, Wang Y, Wei W, Yin C and Tang F: Effects of Saikosaponin D on CYP1A2 and CYP2D6 in HepaRG cells. Drug Des Devel Ther. 14:5251–5258. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Tang Y, Wei W, Yin C and Tang F: Effects of saikosaponin-d on CYP3A4 in HepaRG cell and protein-ligand docking study. Basic Clin Pharmacol Toxicol. 128:661–668. 2021. View Article : Google Scholar | |
|
Edeline J, Bridgewater J, Campillo-Gimenez B, Neveu E, Phelip JM, Neuzillet C, Boudjema K, Rolland Y, Valle JW, Garin E, et al: Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trials. Hepatology. 79:96–106. 2024. View Article : Google Scholar | |
|
Kelley RK, Bridgewater J, Gores GJ and Zhu AX: Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 72:353–363. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kanno N, Lesage G, Phinizy JL, Glaser S, Francis H and Alpini G: Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-raf activities. Hepatology. 35:1329–1340. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
He H, Guo J, Hu Y, Zhang H, Li X, Zhang J and Jin S: Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling. Acta Biochim Biophys Sin (Shanghai). 55:1404–1414. 2023.PubMed/NCBI | |
|
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Ning N, Li X, Nan Y, Chen G, Huang S, Du Y, Gu Q, Li W and Yuan L: Molecular mechanism of Saikosaponin-d in the treatment of gastric cancer based on network pharmacology and in vitro experimental verification. Naunyn Schmiedebergs Arch Pharmacol. 397:8943–8959. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Klein AP: Pancreatic cancer epidemiology: Understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 18:493–502. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Xu X, Cui L, Zhang L, Yang L, Zhuo Y and Li C: Saikosaponin d modulates the polarization of tumor-associated macrophages by deactivating the PI3K/AKT/mTOR pathway in murine models of pancreatic cancer. Int Immunopharmacol. 122:1105792023. View Article : Google Scholar : PubMed/NCBI | |
|
Cai C, Zhang H, Ou Y, Jiang Y, Zhong D, Qi H and Dang Q: Saikosaponin-d suppresses cell growth in renal cell carcinoma through EGFR/p38 signaling pathway. Neoplasma. 64:518–525. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Rizzo A, Santoni M, Mollica V, Fiorentino M, Brandi G and Massari F: Microbiota and prostate cancer. Semin Cancer Biol. 86:1058–1065. 2022. View Article : Google Scholar | |
|
Yao M, Yang J, Cao L, Zhang L, Qu S and Gao H: Saikosaponin-d inhibits proliferation of DU145 human prostate cancer cells by inducing apoptosis and arresting the cell cycle at G0/G1 phase. Mol Med Rep. 10:365–372. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhong D, Zhang HJ, Jiang YD, Wu P, Qi H, Cai C, Zheng SB and Dang Q: Saikosaponin-d: A potential chemotherapeutics in castration resistant prostate cancer by suppressing cancer metastases and cancer stem cell phenotypes. Biochem Biophys Res Commun. 474:722–729. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ghosh S: Cisplatin: The first metal based anticancer drug. Bioorg Chem. 88:1029252019. View Article : Google Scholar : PubMed/NCBI | |
|
Tsuyoshi H, Wong VKW, Han Y, Orisaka M, Yoshida Y and Tsang BK: Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest. Oncotarget. 8:99825–99840. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tang TT, Jiang L, Zhong Q, Ni ZJ, Thakur K, Khan MR and Wei ZJ: Saikosaponin D exerts cytotoxicity on human endometrial cancer ishikawa cells by inducing apoptosis and inhibiting metastasis through MAPK pathways. Food Chem Toxicol. 177:1138152023. View Article : Google Scholar : PubMed/NCBI | |
|
Meltzer PS and Helman LJ: New horizons in the treatment of osteosarcoma. N Engl J Med. 385:2066–2076. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao L, Li J, Sun ZB, Sun C, Yu ZH and Guo X: Saikosaponin D inhibits proliferation of human osteosarcoma cells via the p53 signaling pathway. Exp Ther Med. 17:488–494. 2019.PubMed/NCBI | |
|
Gao T, Zhao P, Yu X, Cao S, Zhang B and Dai M: Use of Saikosaponin D and JNK inhibitor SP600125, alone or in combination, inhibits malignant properties of human osteosarcoma U2 cells. Am J Transl Res. 11:2070–2080. 2019.PubMed/NCBI | |
|
Li Y, Cai T, Zhang W, Zhu W and Lv S: Effects of Saikosaponin D on apoptosis in human U87 glioblastoma cells. Mol Med Rep. 16:1459–1464. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Liu G, Guan Y, Liu Y, Wang Y, Zhang J, Liu Y and Liu X: Saikosaponin D inducing apoptosis and autophagy through the activation of endoplasmic reticulum stress in glioblastoma. Biomed Res Int. 2022:54895532022. View Article : Google Scholar : PubMed/NCBI | |
|
McKinnon C, Nandhabalan M, Murray SA and Plaha P: Glioblastoma: Clinical presentation, diagnosis, and management. BMJ. 374:n15602021. View Article : Google Scholar : PubMed/NCBI | |
|
Liang J, Sun J, Liu A, Chen L, Ma X, Liu X and Zhang C: Saikosaponin D improves chemosensitivity of glioblastoma by reducing the its stemness maintenance. Biochem Biophys Rep. 32:1013422022.PubMed/NCBI | |
|
Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, et al: Medulloblastoma. Nat Rev Dis Primers. 5:112019. View Article : Google Scholar : PubMed/NCBI | |
|
Luo J, Wang J, Yang J, Huang W, Liu J, Tan W and Xin H: Saikosaponin B1 and Saikosaponin D inhibit tumor growth in medulloblastoma allograft mice via inhibiting the Hedgehog signaling pathway. J Nat Med. 76:584–593. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Shimony S, Stahl M and Stone RM: Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 98:502–526. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu H, Ni T, Zhang ZS, Zhang T, Li C, et al: Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia. Cancer Cell. 35:677–691.e10. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, Huang H, Nachtergaele S, Dong L, Hu C, et al: FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase. Cancer Cell. 31:127–141. 2017. View Article : Google Scholar | |
|
Sun K, Du Y, Hou Y, Zhao M, Li J, Du Y, Zhang L, Chen C, Yang H, Yan F, et al: Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m6A signaling. Theranostics. 11:5831–5846. 2021. View Article : Google Scholar : | |
|
Wang S, Long S and Wu W: Application of traditional chinese medicines as personalized therapy in human cancers. Am J Chin Med. 46:953–970. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Luo Y, Wang CZ, Hesse-Fong J, Lin JG and Yuan CS: Application of Chinese medicine in acute and critical medical conditions. Am J Chin Med. 47:1223–1235. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xue J, Xu Z, Wang Q, Hou H, Wei L, Zhang J, Zhao X, Chen L, Ding F, Ma L, et al: Clinical practice guidelines for prevention and treatment of postoperative gastrointestinal disorder with Integrated Traditional Chinese and Western Medicine (2023). J Evid Based Med. 17:207–223. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang S, Liu M and Zhao L: Effects of different Chinese traditional exercises on mental health during the COVID-19 pandemic: A systematic review and meta-analysis. Front Public Health. 12:14200352024. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Li X, Huang N, Liu R and Sun R: A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins. Phytomedicine. 50:73–87. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen MH, Gu YY, Zhang AL, Sze DM, Mo SL and May BH: Biological effects and mechanisms of matrine and other constituents of Sophora flavescens in colorectal cancer. Pharmacol Res. 171:1057782021. View Article : Google Scholar : PubMed/NCBI | |
|
Shah MA, Abuzar SM, Ilyas K, Qadees I, Bilal M, Yousaf R, Kassim RMT, Rasul A, Saleem U, Alves MS, et al: Ginsenosides in cancer: Targeting cell cycle arrest and apoptosis. Chem Biol Interact. 382:1106342023. View Article : Google Scholar : PubMed/NCBI | |
|
Alam P, Imran M, Gupta DK and Akhtar A: Formulation of transliposomal nanocarrier gel containing strychnine for the effective management of skin cancer. Gels. 9:8312023. View Article : Google Scholar : PubMed/NCBI | |
|
Liu L, Yan J, Cao Y, Yan Y, Shen X, Yu B, Tao L and Wang S: Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways. Oncol Lett. 21:702021. View Article : Google Scholar | |
|
Zhou P, Shi W, He XY, Du QY, Wang F and Guo J: Saikosaponin D: Review on the antitumour effects, toxicity and pharmacokinetics. Pharm Biol. 59:1480–1489. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang F, Chen L, Jin H, Shao J, Wu L, Lu Y and Zheng S: Activation of Fas death receptor pathway and Bid in hepatocytes is involved in saikosaponin D induction of hepatotoxicity. Environ Toxicol Pharmacol. 41:8–13. 2016. View Article : Google Scholar | |
|
Farhan M: Green Tea Catechins: Nature's way of preventing and treating cancer. Int J Mol Sci. 23:107132022. View Article : Google Scholar : PubMed/NCBI | |
|
Islam MR, Akash S, Rahman MM, Nowrin FT, Akter T, Shohag S, Rauf A, Aljohani ASM and Simal-Gandara J: Colon cancer and colorectal cancer: Prevention and treatment by potential natural products. Chem Biol Interact. 368:1101702022. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Z, Xiao T, Li Z, Zhang J and Chen S: Novel Chemicals derived from tadalafil exhibit PRMT5 inhibition and promising activities against breast cancer. Int J Mol Sci. 23:48062022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao N, Wang W, Jiang H, Qiao Z, Sun S, Wei Y, Xie X, Li H, Bi X and Yang Z: Natural products and gastric cancer: cellular mechanisms and effects to change cancer progression. Anticancer Agents Med Chem. 23:1506–1518. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang GS, Hu PY, Li DX, He MZ, Rao XY, Luo XJ, Wang YS and Wang YR: Formulations, hemolytic and pharmacokinetic studies on saikosaponin a and saikosaponin d compound liposomes. Molecules. 20:5889–5907. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shimizu K, Amagaya S and Ogihara Y: Structural transformation of saikosaponins by gastric juice and intestinal flora. J Pharmacobiodyn. 8:718–725. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J, Xue Y, Sun J, Fu R, Ren S, Zhang Z and Song R: Pharmacokinetics and oral bioavailability studies of three saikogenins in rats using a validated UFLC-MS/MS method. J Chromatogr B Analyt Technol Biomed Life Sci. 1124:265–272. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ye HN, Liu XY and Qin BL: Research progress of integrated traditional Chinese and Western medicine in the treatment of advanced gastric cancer. World J Gastrointest Oncol. 15:69–75. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Ma L, Wang B, Long Y and Li H: Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: A systematic review with meta-analysis. Front Med. 11:191–202. 2017. View Article : Google Scholar : PubMed/NCBI |
